TITLE

The "file drawer" phenomenon: suppressing clinical evidence

PUB. DATE
February 2004
SOURCE
CMAJ: Canadian Medical Association Journal;2/17/2004, Vol. 170 Issue 4, p437
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
Discusses the state of the clinical trials in Canada as of February 2004. Reason most clinical trial results are never reported in the public domain; Concealment of unfavorable evidence in clinical trials of selective serotonin reuptake inhibitors in children; Issue on the Merck guidelines for clinical trials.
ACCESSION #
12157865

 

Related Articles

  • Lessons learned from the STAR*D depression trial. Denninger, John W. // Patient Care;Mar2007, Vol. 41 Issue 3, p27 

    The article provides information on the Sequenced Treatment Alternatives to Relieve Depression clinical trial in the U.S. According to the author, the purpose of this trial was to assess the effectiveness of various sequential treatment options in patients with nonpsychotic major depressive...

  • Lessons learned from the STAR*D depression trial. Denninger, John W. // Patient Care for the Nurse Practitioner;Mar2007, Vol. 10 Issue 3, p4 

    The article provides information on the Sequenced Treatment Alternatives to Relieve Depression (STARD) clinical trial which aimed to assess the effectiveness of various sequential treatment options in patients with nonpsychotic major depressive disorder (MDD) who do not achieve remission on the...

  • Triple Reuptake Inhibitors: Next-Generation Antidepressants. Yanqi Liang; Richelson, Elliott // Primary Psychiatry;Apr2008, Vol. 15 Issue 4, p50 

    A major advance in the pharmacotherapy of depression was the introduction of the selective serotonin reuptake inhibitors nearly 2 decades ago. These drugs succeed in treating depressed patients with few of the side effects common to tricyclic antidepressants, which they largely replaced....

  • Disparate findings on a link between SSRIs and suicide. Paist, Scott S.; Russell, John J. // Patient Care;May2005, Vol. 39 Issue 5, p62 

    Presents information on two articles about the occurrences of suicide and intentional self-harm following the initiation of selective serotonin reuptake inhibitor (SSRI) therapy for depression. "Selective Serotonin Reuptake Inhibitors and Suicide in Adults: Meta-analysis of Drug Company Data...

  • UPLIFTING DEPRESSION.  // American Herb Association Quarterly Newsletter;Winter2006, Vol. 21 Issue 2, p12 

    The article reports on St. John's wort extract from Germany, which was proven to be as effective as the pharmaceutical antidepressant Paxil, a selective serotonin reuptake inhibitor, which is generically called paroxetine. The herb extract achieved better results than Paxil on the Depression...

  • Trial analysis questions use of antidepressants in children. Check, Erika // Nature;4/15/2004, Vol. 428 Issue 6984, p682 

    Focuses on the clinical trial related to the use of antidepressants known as serotonin reuptake inhibitors by children in Australia. Advantage of the drugs; Potential to increase of risk of suicide associated with drug intake; Comparison of results between antidepressants and cognitive...

  • Study backs GP ban on SSRIs.  // Pulse;11/9/2006, Vol. 66 Issue 42, p13 

    The article reports on the increased risk of suicidal behavior among young people who are taking selective serotonin reuptake inhibitors in Great Britain. According to a study conducted by Dr. Bernadka Duicka and her team, the suicidal rate has escalated by 70%. She recommended a single,...

  • Fluoxetine dose and outcome in antidepressant drug trials. Barbui, Corrado; Hotopf, Matthew; Garattini, Silvio // European Journal of Clinical Pharmacology;Sep2002, Vol. 58 Issue 6, p379 

    Objective. One potential for bias in the evaluation of a new drug is the dose used, both for the new compound and for the reference drug. The present study compared fluoxetine dose and outcome in trials in which fluoxetine was the experimental drug with trials in which it was the comparator....

  • Selective Serotonin Reuptake Inhibitors and Intraoperative Blood Pressure. van Haelst, Ingrid M.M.; van Klei, Wilton A.; Doodeman, Hieronymus J.; Kalkman, Cor J.; Egberts, Toine C.G. // American Journal of Hypertension;Feb2012, Vol. 25 Issue 2, p223 

    BackgroundThe influence of selective serotonin reuptake inhibitors (SSRIs) on blood pressure is poorly understood. We hypothesized that if SSRIs have an influence on blood pressure, this might become manifest in changes in intraoperative blood pressure. We aimed to study the association between...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics